A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

NCT01228747 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

361

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Generalized Tonic-Clonic Seizures

Interventions

DRUG: Levetiracetam
DRUG: Placebo

Sponsor

UCB Japan Co. Ltd.